Anti-Inhibitor Coagulant Complex- Heat Treated Medication Information
Discover comprehensive details about Anti-Inhibitor Coagulant Complex- Heat Treated, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it.
The updated prescription information covers potential side effects, precautions, warnings, and storage recommendations.
Additionally, explore the Anti-Inhibitor Coagulant Complex- Heat Treated brands available in India and internationally, along with pricing information. For personalized advice, consult your healthcare provider.
Generic Name : Anti-Inhibitor Coagulant Complex- Heat Treated Pronunciation : koe-AG-ue-lant ICD Code : Y44.2 Therapeutic Classification : Anticoagulants / AntithromboticsBrand Names or Trade Names of Anti-Inhibitor Coagulant Complex- Heat Treated
International :
Autoplex- T, Feiba NF, Feiba VH Immuno
Why is Anti-Inhibitor Coagulant Complex- Heat Treated Prescribed? (Indications)
This medication is a clotting factor, prescribed for bleeding episodes or bleeding during surgery in patients with Factor VIII inhibitors.When should Anti-Inhibitor Coagulant Complex- Heat Treated not be taken? (Contraindications)
Contraindicated in patients with disseminated intravascular coagulation (DIC), normal blood clotting, and hypersensitivity.What is the dosage of Anti-Inhibitor Coagulant Complex- Heat Treated?
IV- The recommended dosage range is 25 to 100 Hyland Factor VIII Correctional Units per kg of body weight.How should Anti-Inhibitor Coagulant Complex- Heat Treated be taken?
It comes as a solution for injection, to be administered by a healthcare provider into the vein.What are the warnings and precautions for Anti-Inhibitor Coagulant Complex- Heat Treated?
• Caution should be exercised in patients with history of crush injury, heart disease, narrowing of blood vessels, liver impairment, blood infection, or disseminated intravascular coagulation (DIC), recent heart attack, who are taking other medications, any allergy, elderly, newborns, during pregnancy and breastfeeding.• It may cause dizziness, do not drive a car or operate machinery while taking this medication.
• Rarely patient may develop with viral disease (e.g., hepatitis, parvovirus B19) or a central nervous system disease called Creutzfeldt-Jakob disease; discuss about this with your healthcare provider before taking this medication.
• Monitor blood pressure, fibrinogen counts, and platelet counts regularly while taking this medication.
